Back to Results

The effect of topiramate on etonogestrel concentrations in contraceptive implant users

Study category: Healthy Volunteers

Is this Study for You?

Let's Get Started!

Details
Age

Adult

Eligibility

Healthy, reproductive-aged females who have had the ENG implant between one and three years

Phase

IV - Research Studies occurring after FDA has approved a drug for marketing. These studies gather additional information about a drug's safety, efficacy, or optimal use.

Type of Study

Other

Locations

Comprehensive Women's Health Center
Comprehensive Womens Health Center
University of Colorado Hospital

Principal Investigator
Stephanie Teal,  MD

Stephanie Teal, MD

Study ID

Protocol Number: 17-1047

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers